New Skin Reaction Warning for Seizure Rx
Side effects are unfortunately a risk that come with many medications. This week, health officials are warning that an anti-seizure medication has been tied to serious skin reactions.
FDA Warns of Serious Skin Reactions with Anti-Seizure Rx
The U.S. Food and Drug Administration (FDA) is warning the public that the anti-seizure drug Onfi (clobazam) can cause rare but serious skin reactions that can result in permanent harm and death.
FDA approves Onfi to treat severe type of seizures
On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets ( clobazam ) for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older.